Table 2.

Univariate analysis of variables predicting overall survival.

Variable	P value	HR (CI)
Gender
Male (n = 130)	0.017	1.46 (1.06 – 1.87)
Female (n = 30)
Age
≥60 (n = 50)	0.050	1.32 (1.17 – 2.01)
<60 (n = 110)
Etiology of Cirrhosis
HCV (n = 75)	0.042	1.87 (1.31 - 3.76)
Non-HCV (n = 85)
Biochemical MELD score at diagnosis
< 15 (n = 111)	0.013	3.14 (1.41 - 4.88)
≥ 15 (n = 49)
AFP at diagnosis (ng/dL)
≥ 400 (n = 52)	0.029	2.61 (1.91 – 3.10)
< 400 (n = 108)
Outside Milan criteria at diagnosis
Yes (n = 26)	0.571	9.76 (0.19 – 16.71)
No (n = 134)
Time on wait list (days)
< 30 days (n = 96)	0.610	1.18 (0.82 - 1.71)
≥ 30 days (n = 64)
Locoregional therapy prior to transplantation
Yes (n = 110)
No (n = 50)	0.058	1.39 (0.98 - 1.92)
Incidental HCC
Yes (n = 15)	0.980	0.85 (0.08 - 2.77)
No (n = 145)
Tumor stage underestimated by pre-operative imaging	0.781	1.42 (0.84 – 2.14)
Yes (n = 8)
No (n = 152)
Poorly differentiated tumor on explant
Yes (n = 21)	0.767	1.08 (0.88 – 1.65)
No (n = 139)
Any tumor greater than 3cm in diameter
Yes (n = 66)	0.799	1.48 (0.09 – 1.76)
No (n = 64)
NLR at time of diagnosis
≥5 (n = 28)	0.032	2.12 (1.41 – 4.62)
<5 (n = 132)
Microvascular invasion
Yes (n = 25)	0.047	1.66 (1.39 – 3.70)
No (n = 135)